{
    "General": {
        "Code": "IDDA",
        "Type": "Common Stock",
        "Name": "INNATE PHARMA SP.ADR/1",
        "Exchange": "F",
        "CurrencyCode": "EUR",
        "CurrencyName": "Euro",
        "CurrencySymbol": "\u20ac",
        "CountryName": "Germany",
        "CountryISO": "DE",
        "OpenFigi": null,
        "ISIN": "US45781K2042",
        "LEI": null,
        "PrimaryTicker": null,
        "CIK": null,
        "EmployerIdNumber": null,
        "FiscalYearEnd": "December",
        "IPODate": null,
        "InternationalDomestic": null,
        "Sector": "Healthcare",
        "Industry": "Biotechnology",
        "GicSector": "Health Care",
        "GicGroup": "Pharmaceuticals, Biotechnology & Life Sciences",
        "GicIndustry": "Biotechnology",
        "GicSubIndustry": "Biotechnology",
        "Description": "Innate Pharma S.A., a biotechnology company, develops immunotherapies for cancer patients in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and peripheral T-cell lymphoma, as well as in Phase II clinical trials to treat refractory s\u00e9zary syndrome; Monalizumab, an immune checkpoint inhibitor that is in Phase III clinical trial to treat advanced solid tumors comprising colorectal and lung cancer, as well as head and neck cancer; Avdoralimab (IPH5401), an Anti-C5aR Antibody; IPH5201, a blocking antibody that is in Phase 1 clinical trials targeting the CD39 immunosuppressive pathway; IPH5301, an anti-CD73 antibody targeting the immunosuppressive adenosine pathway to promote antitumor immunity; IPH6401, an BCMA-targeting NK cell engager; and IPH6101, a NKp46-based NK cell engager that targets CD123 proprietary multi-specific antibody format; and IPH62, an B7-H3-targeting NK cell engager. Its products in preclinical trials are IPH43, an anti-MICA/B ADC and IPH4501, an antibody drug conjugates (ADC); and IPH65, a tetra-specific proprietary antibody. The company has licensing and collaboration agreements with AstraZeneca, Novo Nordisk A/S, Sanofi, and Orega Biotech; and co-development and license agreement with MedImmune Limited. Innate Pharma S.A. was incorporated in 1999 and is headquartered in Marseille, France.",
        "Address": null,
        "AddressData": null,
        "Listings": {},
        "Officers": {},
        "Phone": null,
        "WebURL": null,
        "LogoURL": "",
        "FullTimeEmployees": 211,
        "UpdatedAt": "2023-08-30"
    },
    "Highlights": {
        "MarketCapitalization": 216845808,
        "MarketCapitalizationMln": 216.8458,
        "EBITDA": -12020000,
        "PERatio": null,
        "PEGRatio": null,
        "WallStreetTargetPrice": 10.3,
        "BookValue": 0.675,
        "DividendShare": 0,
        "DividendYield": 0,
        "EarningsShare": -0.73,
        "EPSEstimateCurrentYear": 0,
        "EPSEstimateNextYear": 0,
        "EPSEstimateNextQuarter": 0,
        "EPSEstimateCurrentQuarter": 0,
        "MostRecentQuarter": "2022-12-31",
        "ProfitMargin": -1.0074,
        "OperatingMarginTTM": -0.2848,
        "ReturnOnAssetsTTM": -0.0432,
        "ReturnOnEquityTTM": -0.7175,
        "RevenueTTM": 57674000,
        "RevenuePerShareTTM": 0.724,
        "QuarterlyRevenueGrowthYOY": 0.061,
        "GrossProfitTTM": -22301000,
        "DilutedEpsTTM": -0.73,
        "QuarterlyEarningsGrowthYOY": 0
    },
    "Valuation": {
        "TrailingPE": 0,
        "ForwardPE": 0,
        "PriceSalesTTM": 0,
        "PriceBookMRQ": 0,
        "EnterpriseValue": 134834256,
        "EnterpriseValueRevenue": 0,
        "EnterpriseValueEbitda": 0
    },
    "SharesStats": {
        "SharesOutstanding": 80498000,
        "SharesFloat": 30119874,
        "PercentInsiders": 0,
        "PercentInstitutions": 0.615,
        "SharesShort": null,
        "SharesShortPriorMonth": null,
        "ShortRatio": null,
        "ShortPercentOutstanding": null,
        "ShortPercentFloat": null
    },
    "Technicals": {
        "Beta": 0.2562,
        "52WeekHigh": 3.6,
        "52WeekLow": 1.66,
        "50DayMA": 2.6432,
        "200DayMA": 2.6477,
        "SharesShort": 0,
        "SharesShortPriorMonth": 0,
        "ShortRatio": 0,
        "ShortPercent": 0
    },
    "SplitsDividends": {
        "ForwardAnnualDividendRate": 0,
        "ForwardAnnualDividendYield": 0,
        "PayoutRatio": 0,
        "DividendDate": null,
        "ExDividendDate": null,
        "LastSplitFactor": null,
        "LastSplitDate": null,
        "NumberDividendsByYear": {}
    },
    "Holders": null,
    "InsiderTransactions": {},
    "outstandingShares": {
        "annual": {},
        "quarterly": {}
    },
    "Earnings": {
        "History": {},
        "Trend": {
            "2020-12-31": {
                "date": "2020-12-31",
                "period": "+1y",
                "growth": null,
                "earningsEstimateAvg": "0.0000",
                "earningsEstimateLow": "0.0000",
                "earningsEstimateHigh": "0.0000",
                "earningsEstimateYearAgoEps": null,
                "earningsEstimateNumberOfAnalysts": "0.0000",
                "earningsEstimateGrowth": null,
                "revenueEstimateAvg": "85641600.00",
                "revenueEstimateLow": "76100000.00",
                "revenueEstimateHigh": "145440000.00",
                "revenueEstimateYearAgoEps": null,
                "revenueEstimateNumberOfAnalysts": "4.00",
                "revenueEstimateGrowth": "-0.1500",
                "epsTrendCurrent": "0.0000",
                "epsTrend7daysAgo": "-0.1700",
                "epsTrend30daysAgo": "-0.1700",
                "epsTrend60daysAgo": "-0.1700",
                "epsTrend90daysAgo": "-0.1700",
                "epsRevisionsUpLast7days": "0.0000",
                "epsRevisionsUpLast30days": "0.0000",
                "epsRevisionsDownLast7days": null,
                "epsRevisionsDownLast30days": "0.0000"
            },
            "2019-12-31": {
                "date": "2019-12-31",
                "period": "0y",
                "growth": null,
                "earningsEstimateAvg": "0.0000",
                "earningsEstimateLow": "0.0000",
                "earningsEstimateHigh": "0.0000",
                "earningsEstimateYearAgoEps": null,
                "earningsEstimateNumberOfAnalysts": "0.0000",
                "earningsEstimateGrowth": null,
                "revenueEstimateAvg": "100714000.00",
                "revenueEstimateLow": "99000000.00",
                "revenueEstimateHigh": "120240000.00",
                "revenueEstimateYearAgoEps": null,
                "revenueEstimateNumberOfAnalysts": "2.00",
                "revenueEstimateGrowth": null,
                "epsTrendCurrent": "0.0000",
                "epsTrend7daysAgo": "0.0600",
                "epsTrend30daysAgo": "0.0600",
                "epsTrend60daysAgo": "0.0600",
                "epsTrend90daysAgo": "0.0600",
                "epsRevisionsUpLast7days": "0.0000",
                "epsRevisionsUpLast30days": "0.0000",
                "epsRevisionsDownLast7days": null,
                "epsRevisionsDownLast30days": "0.0000"
            },
            "2019-09-30": {
                "date": "2019-09-30",
                "period": "0q",
                "growth": null,
                "earningsEstimateAvg": "0.0000",
                "earningsEstimateLow": "0.0000",
                "earningsEstimateHigh": "0.0000",
                "earningsEstimateYearAgoEps": null,
                "earningsEstimateNumberOfAnalysts": "0.0000",
                "earningsEstimateGrowth": null,
                "revenueEstimateAvg": "0.00",
                "revenueEstimateLow": "30170000.00",
                "revenueEstimateHigh": "30170000.00",
                "revenueEstimateYearAgoEps": null,
                "revenueEstimateNumberOfAnalysts": "1.00",
                "revenueEstimateGrowth": null,
                "epsTrendCurrent": "0.0000",
                "epsTrend7daysAgo": "0.0400",
                "epsTrend30daysAgo": "0.0400",
                "epsTrend60daysAgo": "0.0400",
                "epsTrend90daysAgo": "0.0400",
                "epsRevisionsUpLast7days": "0.0000",
                "epsRevisionsUpLast30days": "0.0000",
                "epsRevisionsDownLast7days": null,
                "epsRevisionsDownLast30days": "0.0000"
            }
        },
        "Annual": {}
    },
    "Financials": {
        "Balance_Sheet": {
            "currency_symbol": null,
            "quarterly": {},
            "yearly": {}
        },
        "Cash_Flow": {
            "currency_symbol": null,
            "quarterly": {},
            "yearly": {}
        },
        "Income_Statement": {
            "currency_symbol": null,
            "quarterly": {},
            "yearly": {}
        }
    }
}